HomeHBPCF • OTCMKTS
add
Helix Biopharma Corp
Previous close
$1.73
Year range
$0.59 - $1.73
Market cap
183.31M CAD
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Oct 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 928.00K | -41.78% |
Net income | -1.01M | 24.55% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -926.00K | 41.76% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Oct 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 498.00K | 118.42% |
Total assets | 19.07M | 4,505.31% |
Total liabilities | 3.00M | 68.73% |
Total equity | 16.07M | — |
Shares outstanding | 75.87M | — |
Price to book | 8.26 | — |
Return on assets | -12.25% | — |
Return on capital | -14.35% | — |
Cash Flow
Net change in cash
| (CAD) | Oct 2025info | Y/Y change |
|---|---|---|
Net income | -1.01M | 24.55% |
Cash from operations | -1.22M | -41.93% |
Cash from investing | — | — |
Cash from financing | 1.66M | — |
Net change in cash | 433.00K | 150.76% |
Free cash flow | -650.88K | -22.14% |
About
Founded
1995
Headquarters
Website
Employees
7
